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Abstract
Purpose Mortality prediction models for patients with
perforated peptic ulcer (PPU) have not yielded consistent
or highly accurate results. Given the complex nature of this
disease, which has many non-linear associations with out-
comes, we explored artificial neural networks (ANNs) to
predict the complex interactions between the risk factors of
PPU and death among patients with this condition.
Methods ANN modelling using a standard feed-forward,
back-propagation neural network with three layers (i.e., an
input layer, a hidden layer and an output layer) was used to
predict the 30-day mortality of consecutive patients from a
population-based cohort undergoing surgery for PPU. A
receiver-operating characteristic (ROC) analysis was used
to assess model accuracy.
Results Of the 172 patients, 168 had their data included
in the model; the data of 117 (70 %) were used for the
training set, and the data of 51 (39 %) were used for the
test set. The accuracy, as evaluated by area under the ROC
curve (AUC), was best for an inclusive, multifactorial
ANN model (AUC 0.90, 95 % CIs 0.85–0.95; p \ 0.001).
This model outperformed standard predictive scores,
including Boey and PULP. The importance of each vari-
able decreased as the number of factors included in the
ANN model increased.
Conclusions The prediction of death was most accurate
when using an ANN model with several univariate
influences on the outcome. This finding demonstrates that
PPU is a highly complex disease for which clinical prog-
noses are likely difficult. The incorporation of computer-
ised learning systems might enhance clinical judgments to
improve decision making and outcome prediction.
Keywords Peptic ulcer perforation  Gastroduodenal
ulcers  Mortality  Prediction  Prognosis  Outcome
assessment  Computer simulation
Introduction
Perforated peptic ulcers (PPUs) are the leading cause of
surgery-related death worldwide [1]. Although the inci-
dence of peptic ulcer complications due to bleeding has
decreased [2], the incidence of perforations has remained
stable over the past few decades despite surgical and
medical advancements. PPU is a severe complication of
peptic ulcer disease with a reported mortality of approxi-
mately 10–20 %, even in modern surgical series [3–7].
Mortality prediction is of importance, but previous
models have yielded inconsistent results [8, 9]. Further, the
Boey score [10] as one of the most frequently used scores
was created on patient series during the 1980s, which may
explain why results vary across studies [9]. In fact, we
recently demonstrated that no predictive models has
superior accuracy [11]; at best, only 4 out of 5 patients are
correctly classified by any particular model.
Notably, although prediction was improved by a previ-
ous model that combined six pre-operatively obtainable
variables [11], the prognostic value of any single factor was
limited. This limitation might be explained by the fact that
biological systems have relationships between the variables
that are complex, multidimensional and non-linear.
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The increasing availability of electronic medical infor-
mation that can be collected and used for pattern recog-
nition has created new opportunities to improve diagnoses
and predictions of disease outcomes [12–15]. Computers
can gather and process thousands of variables as well as
learn to recognise patterns by simulated ‘‘trial-and-error’’
processing—often referred to as ‘‘artificial intelligence’’.
One such type of artificial intelligence is the artificial
neural network (ANN). ANNs are information-processing
paradigms inspired by the analytical processes of the
human brain. Emerging data have demonstrated the supe-
riority of ANN modelling with regard to several benign or
malignant gastrointestinal disorders [16–19]; however,
ANNs have never been applied to predict PPU outcomes.
Thus, our objective was to explore the ability of an ANNto
improve survival prediction.
Materials and methods
The study was approved as a quality control assurance
project according to the Regional Ethics Committee (REK
Vest # 2011/713). The study complied with the Strength-
ening the Reporting of Observational Studies in Epidemi-
ology (STROBE) statement, where applicable [20].
The study cohort has been described in detail elsewhere
[11]. A population-based consecutive series of 172 patients
diagnosed and operated on for perforated gastroduodenal
ulcer between January 2001 and December 2010 were
included in the current study. Patients with perforations
caused by malignant disease (i.e., gastric cancer) and
patients who did not undergo surgery were excluded from
the current study. The primary endpoint of this study was
the 30-day mortality after surgery for PPU.
The clinical and laboratory variables have been defined
previously [11]. Optimal cut-off values were established
using ROC analysis for dichotomising continuous variables,
as described elsewhere [21]. Both the Boey score [22] and
the PULP score [23] have been described elsewhere.
Predicted probabilities from regression analyses
A multivariate regression analysis was performed as pre-
viously described [11] to evaluate the current PPU scoring
systems, including Boey and PULP. For the regression
models, the saved probabilities for each patient in the
model (either Boey or PULP) were used for comparison
with the output values generated for ANN modelling in the
current study.
In the previous multivariate regression model that used
the same material [11], mortality was best predicted based
on a combination of negative prognostic factors: increasing
age, the presence of an active cancer, a delay from
admission to surgery [24 h, hypoalbuminaemia, hyperbi-
lirubinaemia and increasing creatinine values. The predic-
tive probabilities for the multivariate model had an AUC of
0.89.
Statistical analyses
The data were analysed using the Statistical Package for
Social Sciences (IBM SPSS v. 21, Inc. for Mac).
The ANN model used in the current study was a mul-
tilayer perceptron (MLP) network conducted as a standard
feed-forward, back-propagation neural network with three
layers: an input layer, a hidden layer and an output layer.
The MLP network is a tool for designing special classes of
layered feed-forward networks. The input layer consists of
source nodes, and its output layer consists of neurons; these
layers connect the network to the outside world. In addition
to these layers, the MLP usually has one or more layers of
neurons referred to as hidden neurons because they are not
directly accessible. The hidden neurons extract important
features contained in the input data.
The patients were randomly divided into a training/
cross-validation group (70 %) and an internal validation
group (30 %). The training/cross-validation group was
used to train the network.
We initially constructed the present MLP network with
six input neurons derived from the previous logistic
regression model, which included only objective and
reproducible laboratory variables (i.e., age, surgical delay,
the presence of active cancer and blood laboratory values
for serum albumin, bilirubin and creatinine).
Definitions of the ANN models
The experimental design is visualised in Fig. 1. The first
model (hereafter referred to as model #1) was created using
the same input variables as previously established in uni-
and multivariate regression analyses [11], with dichoto-
mised variables for continuous data based on optimal cut-
off values in the ROC analysis (e.g., to indicate hypoal-
buminaemia, hyperbilirubinaemia and increased creatinine
values; Table 1). In the second model (model #2), the same
variables were included but used as non-dichotomised,
continuous values to allow the model to adjust the role of
each variable throughout the spectrum of values.
Finally, a third model (model #3) was created to explore
the enhanced capabilities and unknown interactions of
variables. This model included all of the potential factors
that might be associated with mortality, including gender,
the presence of shock at admission, sepsis and mode of
surgery.
To compare these three models, the output predictive
value for each ANN was compared using ROC analysis and
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95 % confidence intervals. All p values \0.050 were
considered significant.
Results
A total of 172 patients were included; 28 deaths occurred
within 30 days of surgery (16 %). The baseline data are
presented in Table 2. The networks created for ANN
models #1 and #2 are shown in Fig. 1. The six input nodes
resulted in different hidden layers for outcome predictions
when either dichotomised (Fig. 2a) or continuous (Fig. 2b)
variables were imputed. Notably, the accuracy of the model
was reduced by the latter approach (Table 3).
ANN model #1 had an accuracy that was somewhat
lower than that of a previously reported regression model.
The AUC of the ANN was 0.84, whereas the AUC of the
logistic regression model was 0.89 using the same variables
[11]. The accuracy of the model decreased (model #2)
when the variables were input as continuous measures
(Table 3). Increasing the available information in the
model by liberally including numerous variables (ANN
model #3) with an unknown relationship to the outcome
improved the accuracy of the model to AUC 0.90 (Table 3;
Fig. 1 Flow-chart of
experiment for each model.
Asterisk regression based on
variables selected in
multivariable analyses from
Thorsen et al. [11]
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Fig. 3). In clinical terms, this result means that the model
should accurately predict death in 9 out of 10 patients
undergoing an operation for PPU.
The constructed graphs for each model in the network
analysis suggest that accuracy increased when more vari-
ables were added to the model (Fig. 3). When including
additional variables such as the presence of comorbidities
(e.g., cardiovascular, pulmonary or autoimmune diseases),
the accuracy of the model decreased (data not shown),
which indicates that additional predictive information was
not available.
Furthermore, as the number of variables in the models
increased, the predictive value of each variable decreased
considerably (Fig. 4a–c). In fact, the incremental input
from each variable was small (Fig. 4c), although the
model’s prediction accuracy increased (Fig. 3). In addition,
the relative contribution of each variable changed consid-
erably (Fig. 4a–c), as expressed by the variable
importance.
The weighted importance of the factors changed; a
strong emphasis was placed on CRP, creatinine and bili-
rubin; however, the other factors (including age, shock,
active cancer or other risk factors) exerted virtually no
effect.
ANN model #3 was more accurate than a previously
reported multivariate regression model based on increasing
age, the presence of active cancer, an admission delay for
surgery of[24 h, hypoalbuminaemia, hyperbilirubinaemia
and increased creatinine values (model AUC of 0.89) [11].
However, the increase in accuracy was not significant
(from an AUC of 0.89–0.90), showing an overlap of the
95 % CIs for both models.
Discussion
This study demonstrated that the application of ANNs to
enhance the outcome predictions regarding patients with
PPU slightly improved upon the predictive ability of a
previously reported regression model [11]. Furthermore,
Table 1 Variables included in
the neural network modelling
For comparison, the variables
included in the Boey and PULP
scores are shown
Factors (units) ANN mod. #1 ANN mod. #2 ANN mod. #3 Boey PULP
Gender (M/F) 4
Age (years) 4 4 4 4
Location of ulcer (duodenal/gastric) 4
Diagnostic delay (h) 4
Delay before surgery (h) 4 4 4 4
Type of surgical repair (lap/open) 4
Comorbidity (any) 4
ASA fitness score (I–V) 4 4
Active cancer disease (y/n) 4 4 4 4
Liver cirrhosis (y/n) 4
Steroid use (y/n) 4
Albumin (g/L) 4 4 4
Bilirubin (lmol/L) 4 4 4
Creatinine (lmol/L) 4 4 4 4
Leucocytes (109/L) 4
C-reactive protein (mg/L) 4
Sepsis on admission (y/n) 4
Shock on admission (y/n) 4 4 4
Table 2 Baseline characteristics of the patients with PPU
Characteristics Total
(n = 172)
Deaths at 30
days (n = 28)
Gender, F:M 89:83 17:11
Age, median years (range) 68 (18–100) 80 (56–95)
Ulcer in prior history (n, %) 26 (15 %) 5 (18 %)
Location of ulcer, duodenal:gastric 60:112 14:14
Delay to surgery, median hours
(range)
6.2
(0.5–116.2)
10.0
(1.1–40.6)
Laparoscopic repair 50 (29 %) 8 (29 %)
Shock at admission 37 (22 %) 10 (37 %)
Sepsis at admission 70 (42 %) 12 (48 %)
ASA fitness score CIII 73 (42 %) 24 (86 %)
Active cancer disease 19 (11 %) 9 (32 %)
Boey score C2 56 (33 %) 18 (64 %)
Steroid use 16 (10 %) 5 (18 %)
The data are presented as numbers and (%) or as medians with ranges
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the ANNs performed better than the currently proposed
Boey and PULP scores for outcome predictions among
patients with PPU. Of note, the ANN models suggested a
difference in the weighted importance of the included
factors that changed based on how the variables were
included and combined in the model. Based on the dif-
ferences in the model inputs and the resulting outputs,
outcome predictions of PPU were complex and likely to be
influenced by several factors that might have unknown
relationships with each other (which cannot be easily
demonstrated using standard near-linear, regression mod-
els). The cumulative presence of unknown and small
relationships might largely explain the difficulty, limited
success and moderate accuracy associated with generating
predictive models consisting of a few (e.g., 3–5) explana-
tory variables, given that the actual outcome depends on a
much greater variance and (at least partially unknown)
interdependence of factors. Drawing an analogy to the
clinical setting, the inexperienced physician may be over-
whelmed of the number of factors to consider, some with
subtle meaning while others are more predominating, thus
preventing the clinician to consider any more than a blunt
few for clinical decision making. In reality, many subtle
factors may indeed point to a potential dire situation that
may easily be missed or go unrecognised by the inexperi-
enced clinician. Situations such as these are where com-
puterised pattern recognition and prediction algorithms can
become useful [24]. Although their full potential has yet to
be reached [25], developments in technology are rapidly
moving toward models that might become available
Fig. 2 Two ANN models. Although the same input variable nodes
were kept, the network and hidden nodes changed when using
continuous data (in model #2) versus dichotomised values (in model
#1), demonstrating a change in the importance and the relationships
between each variable and the outcome
Fig. 3 ROC curve comparing the accuracy of the three ANN models
Table 3 ROC analysis with AUC and 95 % CIs for the different
ANN models
Test result variable(s) AUC AUC 95 % CI P value
Neural network model #1 0.84 0.77–0.91 \0.001
Neural network model #2 0.77 0.67–0.87 \0.001
Neural network model #3 0.90 0.85–0.95 \0.001
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for everyday use. A further example of ‘‘innovation tech-
nology’’ might be the rapid and widespread use of infor-
mation technology such as smart phones and various
applications [26] that only a decade ago seemed futuristic
and at a developmental stage at best.
ANN-based models might even help expert clinicians.
The belief that the brain’s short-term memory can simul-
taneously retain (and therefore optimally use) only 4–7
pieces of information is of importance; attempts to use
larger amounts of information at one time can lead to
ineffective decision-making. Given this limitation, many
clinicians might have difficulty assimilating the many
variables that are often encountered in real-life clinical
environments. This mismatch between innate human abil-
ity (i.e., ‘‘human brain processing capacity’’) and excessive
input data (i.e., ‘‘information overload’’) might contribute
to unnecessary variations in clinical practice (i.e., ‘‘deci-
sion-making’’), poor compliance with established guide-
lines and even errors in medical judgment [27]. In fact,
certain computer systems are beginning to reveal clinical
implications in several areas to improve patient safety and
generate complex data analyses [12–14].
Notably, an experienced clinician may outperform the
ability of an advanced computer prediction models. How-
ever, clinical decision-making is based on the human
ability to collect information and process it into clinically
predictive patterns. This skill is influenced by knowledge,
experience and sources of bias. Knowingly, becoming an
‘‘expert’’ takes thousands of hours of experience—a for-
tune that clinicians do not have from the start and which
may take longer time to require in the current work-
restricted environment [28]. The increasing availability of
electronic medical information that can be collected and
used for pattern recognition has created new opportunities
to improve diagnoses and predictions of disease outcomes
[12–15]. Computers can gather and process thousands of
variables as well as learn to recognise patterns by simulated
‘‘trial-and-error’’ processing, often referred to as ‘‘artificial
intelligence’’. In other words, computers are able to make
informed decisions. Such technology is already in use in
aviation systems, banking technology, industrial robotics
and certain areas of medicine [29, 30]. While we do not
suggest that computer systems will replace human input,
there may be a source for potential improvement in pattern
recognition that the inexperienced human brain is incapa-
ble of, at least until obtaining thousands hours of experi-
ence. It may indeed represent the ‘‘gut feeling’’ of the
experienced clinician that recognise a premonition without
being able to pin-point the exact determinator for it.
The potential medical applications of ANNs include
scenarios in which the relationship between independent
variables and clinical outcomes are poorly understood [31,
32]. Because ANNs are capable of self-training with min-
imal human intervention, many studies of large epidemi-
ology databases have used ANNs in addition to traditional
statistical methods to gain additional insight into the rela-
tionships among variables. Several previous studies have
used ANNs to predict mortality after surgery [16, 33–35].
Fig. 4 Weighted importance of included variables for each model.
Both variable importance and the relative weight (or contribution) of
the predictive models shifted, as indicated on the x-axis of each graph
a for model #1; b for model #2 and c for model #3
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ANNs have also been used to aid in the diagnosis and
determination of disease severity [17, 19, 36]. ANNs are
particularly suited to solving non-linear problems and
analysing complex datasets [32]. As such, ANNs constitute
potent alternative computational tools that are able to
outperform the diagnostic and prognostic accuracy of
classical statistical methods.
Of note, ANNs and other artificial intelligence systems
are only as smart as we make them. Thus, there will always
be a need for human input of what sort of data, the quality
of data and the source of data collection that the ANN may
utilise. Accordingly, the danger of ‘‘garbage-in, garbage
out’’ may exist. Also, most clinicians (and researchers)
may be uncomfortable with the ‘‘hidden nodes’’ which are
essentially unavailable and intangible elements of the
computer process. Also, if input is obtained on a one-time
point basis, it may miss the dynamics of process. However,
in real-time models that captures and process variables
continuously, this limitation may be overcome. One
example may be the continuous monitoring performed in
intensive care units, for which considerable data amounts
may be difficult to assess for the human brain, but may
yield threshold values (i.e., express risk of adverse event or
further deterioration) in a learning, artificial intelligence
system.
The current strict, population-based, non-selected cohort
is a particular strength of this study because it reduces
transferral bias or other selection criteria that are found in
regions with coverage overlap between hospitals. However,
all studies have limitations, and the current study is par-
tially limited by its moderately sized sample and reliance
on previously defined predictive variables (e.g., the best
cut-off values for dichotomous variables) for building the
models. A true, secondary and external validation cohort is
lacking. If such a cohort were present, this study would
have enhanced generalizability, but no such cohort was
available when the project began. However, the cohort was
split into training and test sets for the modelling. Notably,
no selection bias was present with regard to the patients
recruited for this study because SUH is the only hospital
that provides care for the target population. Thus, the
results might have external validation with regard to other
Western populations. However, the results might not apply
to perforated ulcer outcomes in regions where this disease
has a different patient profile, such as Africa. Accordingly,
to build on the results from this study, an international
cohort of patients from various geographic regions should
be sought. In addition, a unified agreement concerning data
variables and inclusion is needed because these standards
can differ across studies.
Globally, PPU is associated with a major surgical dis-
ease burden; however, randomised trials and prospective
investigations are few and far between [37]. Additional
international collaborations to increase the power of trials
to generate more robust results should be pursued to
improve care and eventually outcomes [38]. One of the
predetermining factors for creating trials or comparing
outcomes in PPU management is the possibility of allo-
cating patients to risk based on agreed methods and con-
sistent definitions. If the implementation of ANN is
validated in larger and external series, this modelling might
prove beneficial in terms of risk stratification or treatment
allocation in a prospective setting. Notably, the current
ANN model (AUC of 0.90) correctly identified 9 out of 10
patients at risk of dying within 30 days after PPU surgery.
Furthermore, the long-standing issue of non-operative
treatment and defining the best candidates for this treat-
ment does not currently have acceptable prediction models
[39]. Thus, focus should be placed on improving the pre-
diction accuracy to generate reliable and robust models for
future risk stratification and potential treatment allocation
for patients with PPU.
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